Cargando…

“Online survey of COVID-19 immunization and infection in patients with systemic juvenile idiopathic arthritis and adult-onset still’s disease.”

BACKGROUND: Patients with systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease (AOSD) have been under-represented in studies about safety of the COVID-19 immunization. We aimed to inquire about the safety and tolerability of COVID-19 immunization in this population. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marques, Mariana Correia, Paul, Subrata, Lake, Carol, Bergeron, Ly-Lan, Sinha, Rashmi, Peixoto, Luciana, Twilt, Marinka, Ombrello, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664348/ https://www.ncbi.nlm.nih.gov/pubmed/37990257 http://dx.doi.org/10.1186/s12969-023-00911-x

Ejemplares similares

Evaluation of an nhs juvenile idiopathic arthritis (JIA) treatment pathway compared to published international recommendations
por: Green, Katherone L, et al.
Publicado: (2014)

Evaluating key performance indicators of the process of care in juvenile idiopathic arthritis
por: Cooper, Sarah M., et al.
Publicado: (2023)

Joint cartilage thickness and automated determination of bone age and bone health in juvenile idiopathic arthritis
por: Twilt, Marinka, et al.
Publicado: (2017)

The role of etanercept in juvenile dermatomyositis (JDMS) in children
por: Green, Katherine L, et al.
Publicado: (2014)

Orofacial symptoms and oral health-related quality of life in juvenile idiopathic arthritis: a two-year prospective observational study
por: Rahimi, Hanna, et al.
Publicado: (2018)

Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
por: Beukelman, Timothy, et al.
Publicado: (2021)

An Update on the Pathogenic Role of Neutrophils in Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease
por: Kim, Ji-Won, et al.
Publicado: (2021)

Patient factors associated with waiting time to pediatric rheumatologist consultation for patients with juvenile idiopathic arthritis
por: Barber, Claire E. H., et al.
Publicado: (2020)

Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still’s disease
por: Ruscitti, Piero, et al.
Publicado: (2022)

Precision Medicine: The new era in medicine
por: Twilt, Marinka
Publicado: (2016)

mHealth applications are they the future or another burden for our patients?
por: Twilt, Marinka
Publicado: (2023)

The Role of Interleukin 18/Interleukin 18-Binding Protein in Adult-Onset Still’s Disease and Systemic Juvenile Idiopathic Arthritis
por: Girard-Guyonvarc’h, Charlotte, et al.
Publicado: (2022)

Pharmacological treatment patterns in patients with juvenile idiopathic arthritis in the Netherlands: a real-world data analysis
por: Kip, Michelle M A, et al.
Publicado: (2022)

Costs of Hospital‐Associated Care for Patients With Juvenile Idiopathic Arthritis in the Dutch Health Care System
por: Kip, Michelle M. A., et al.
Publicado: (2022)

Testing population-based performance measures identifies gaps in juvenile idiopathic arthritis (JIA) care
por: Barber, Claire E.H., et al.
Publicado: (2019)

Seeking the state of the art in standardized measurement of health care resource use and costs in juvenile idiopathic arthritis: a scoping review
por: Kip, Michelle M. A., et al.
Publicado: (2019)

Foot and Ankle Conventional Radiography in Juvenile Idiopathic Arthritis: Does It Still Matter?
por: Posadzy, Magdalena, et al.
Publicado: (2022)

Factors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritis
por: Grazziotin, Luiza R., et al.
Publicado: (2022)

Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease
por: Sota, Jurgen, et al.
Publicado: (2019)

Roles of Interactions Between Toll-Like Receptors and Their Endogenous Ligands in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease
por: Jung, Ju-Yang, et al.
Publicado: (2020)

Reasons for Initiating Canakinumab among Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease in the U.S. Real-World Settings
por: Hur, Peter, et al.
Publicado: (2021)

Etanercept in juvenile idiopathic arthritis: Who will benefit?
por: Otten, MH, et al.
Publicado: (2011)

Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study
por: Grazziotin, Luiza R., et al.
Publicado: (2022)

Frequency of Fabry disease in a juvenile idiopathic arthritis cohort
por: Paim-Marques, Luciana, et al.
Publicado: (2021)

Gene-expression analysis of adult-onset Still’s disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity
por: Nirmala, Nanguneri, et al.
Publicado: (2015)

Long term functional outcome and quality of life of patients with refractory juvenile idiopathic arthritis treated with etanercept: results of the dutch arthritis and biologicals in children register
por: Anink, Janneke, et al.
Publicado: (2014)

The role of extracellular histones in systemic-onset juvenile idiopathic arthritis
por: Hu, Xiao, et al.
Publicado: (2019)

Treatment of patients with systemic-onset juvenile idiopathic arthritis with tacrolimus
por: Wang, Dongdong, et al.
Publicado: (2019)

Development of consensus best treatment plans for new-onset systemic juvenile idiopathic arthritis
por: Morgan DeWitt, Esi M, et al.
Publicado: (2012)

Application of the international league against rheumatism classification criteria for systemic juvenile idiopathic arthritis as a prognostic factor in patients with adults-onset Still’s disease
por: Yang, Ji Won, et al.
Publicado: (2018)

Similar Clinical Outcomes in Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease Treated with Canakinumab: Bayesian and Population Model-Based Analyses
por: Dunger-Baldauf, Cornelia, et al.
Publicado: (2022)

HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis
por: Ombrello, M, et al.
Publicado: (2015)

Management of Orofacial Manifestations of Juvenile Idiopathic Arthritis: Interdisciplinary Consensus‐Based Recommendations
por: Stoustrup, Peter, et al.
Publicado: (2022)

Time of onset of iridocyclitis (IC) in children with juvenile idiopathic arthritis (JIA)
por: Verazza, S, et al.
Publicado: (2008)

MEFV mutations in Iranian children with systemic onset juvenile idiopathic arthritis
por: Farivar, Shirin, et al.
Publicado: (2014)

Monocytes and neutrophils in the inflammatory cascade of systemic onset Juvenile Idiopathic Arthritis
por: ter Haar, N, et al.
Publicado: (2015)

Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis
por: He, Tingyan, et al.
Publicado: (2023)

Role of polymorphonucleates in the pathogenesis of systemic juvenile idiopathic arthritis and Still's disease: a proof of concept study
por: Magnotti, F, et al.
Publicado: (2015)

Impact of systemic juvenile idiopathic arthritis/Still’s disease on adolescents as evidenced through social media posts
por: Modica, Renee F, et al.
Publicado: (2018)

Atypical clinical presentation of systemic juvenile idiopathic arthritis or Still's disease: a report of two cases
por: Tiogouo, Emeline, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f0ekn8sgdjccac055mlj6od9ct